Skip to main content
Equibles

Connor, Clark & Lunn Investment Management Ltd.

Position in MYGN — Myriad Genetics Inc

CIK 1596800 VANCOUVER, A1
Back to MYGN Full portfolio

Position in MYGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$8,038,880
+$2,104,897 QoQ
Shares Held
1,407,860
+6.8% QoQ
Ownership
1.47%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#21
of 196 holders
Holding Since
Sep 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $189,818,037 across 16 Diagnostics & Research names. MYGN ranks #7 (4.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MEDP
Medpace Holdings, Inc.
 110,353 $58,441,845
2 GH
Guardant Health, Inc.
 215,395 $32,315,711
3 DHR
Danaher Corp /De/
 114,010 $21,716,624
4 TMO
Thermo Fisher Scientific Inc.
 36,269 $18,183,825
5 NEO
Neogenomics Inc
 802,597 $11,709,889
6 RVTY
Revvity, Inc.
 87,145 $9,695,752
7 MYGN
Myriad Genetics Inc
This page 		1,407,860 $8,038,880
8 CSTL
Castle Biosciences Inc
 331,727 $7,911,688

All Filings in MYGN

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,038,880 1,407,860
2026-03-31 $5,933,983 1,318,663
2025-12-31 $7,113,655 1,156,692
2025-09-30 $9,230,815 1,276,738
2025-06-30 $7,369,387 1,387,832
2025-03-31 $8,177,350 921,911
2024-12-31 $7,533,041 549,456
2024-09-30 $3,150,836 115,036
2024-06-30 $534,817 21,865
2023-12-31 $1,174,372 61,357
2023-09-30 $2,185,834 136,274
2023-06-30 $2,774,298 119,685
2023-03-31 $1,404,090 60,443
2022-12-31 $160,117 11,035
2020-12-31 $878,618 44,442
2020-09-30 $1,101,410 84,464